Bausch Health Companies I... (BHC)
NYSE: BHC
· Real-Time Price · USD
6.66
-0.05 (-0.75%)
At close: Sep 24, 2025, 3:59 PM
6.65
-0.07%
After-hours: Sep 24, 2025, 07:55 PM EDT
-0.75% (1D)
| Bid | 6.6 |
| Market Cap | 2.46B |
| Revenue (ttm) | 9.83B |
| Net Income (ttm) | 98M |
| EPS (ttm) | 0.26 |
| PE Ratio (ttm) | 25.6 |
| Forward PE | 1.64 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 6.87 |
| Volume | 1,328,314 |
| Avg. Volume (20D) | 2,709,538 |
| Open | 6.73 |
| Previous Close | 6.71 |
| Day's Range | 6.60 - 6.73 |
| 52-Week Range | 4.25 - 9.85 |
| Beta | 0.48 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for BHC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBausch Health Companies Inc. is scheduled to release its earnings on
Oct 29, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+4.74%
Bausch Health shares are trading higher after the ...
Unlock content with
Pro Subscription
1 month ago
-7.82%
Bausch Health shares are trading lower after the company reported mixed Q2 adjusted EPS results.
4 weeks ago · accessnewswire.com
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX) t...
